We are growing and creating companies that embody our core value of patient-centric, biomedical innovation.

 
 
jeffrey-aronin-castle-creek-logo.jpg

cASTLE creek Pharma

Castle Creek Pharma employs a unique strategy in selective asset identification and capital efficient development that is driving the company to become one of the industry’s most prolific developers of innovative and high potential late stage assets for the treatment of conditions with the greatest medical need. Our particular therapeutic focus is in dermatology and ENT.

jeffrey-aronin-harmony-logo.png

Harmony biosciences

Harmony Biosciences is a biopharmaceutical company focused on identifying, developing, obtaining regulatory approval, and commercializing high-potential, innovative drugs to address unmet needs for patients with sleep and central nervous system (CNS) disorders.

jeffrey-aronin-precision-bp-logo.png

PRECISION BP

Precision is a research and development driven organization focused on developing complex treatments in rare genetic oncology diseases.

jeffrey-aronin-decade-llc-logo.png

Decade Pharmaceuticals

Decade is a research and development company focused on novel Alzheimer’s disease therapeutics that will fundamentally improve patient outcomes and quality of life.